A subgroup analysis revealed that AST indeed associated with higher levels of fibrosis, independent of NAFL or NASH whereas CDCP1 was rather dependent on NAFL or NASH (Figures S4E, F). The gene discussed is CDCP1; the disease is metabolic dysfunction-associated steatohepatitis.